Bacteriology, Virology, BioSafety Testing
Combining general microbiology with modern molecular-based methodologies, CBI offers a very unique complement of services for the isolation and identification of bacterial and viral agents. CBI can support biopharmaceutical and diagnostic programs from discovery to market. CDC and USDA accredited, select agents BSL-3 facilities. GLP and CLIA compliance.
View a printable PDF of this page
Please select a technology to find out more about our Microbiology services:
- General Microbiology
- Molecular-Based Detection
- Biosafety
- BSL-3 Facility
- Biodefense: Detection of Pathogens Including Select Agents
Small and large scale production of aerobic and anaerobic microorganisms
Purification of cellular components
Gram stain and API strip identification
MIC studies
[return to top]
Real-time PCR identification methods and custom assay development
Bacterial identification with 16s ribosomal sequencing
[return to top]
Detection, identification, and quantitation of biopharmaceutical raw materials and process validation
GLP-lot release testing of Vaccines and rDNA products
In vitro assays
Adventitious agents and Mycoplasma
Toxins and endotoxins
Residual DNA/protein
PERT assay for retrovirus enzymes
Sterility testing
Human virus detection in blood-derived products
HIV, HTLV, HBV, EBV, CMV, HCV, Adenovirus
PCR-based detection, ELISA, PERT
[return to top]
Separate BSL-3 facilities for bacterial and viral organisms
CDC and USDA license
Registered to work with select agents and toxins
All work performed under GLP and CLIA
[return to top]
Biodefense: Detection of Pathogens Including Select Agents
Testing of suspect samples or environmental monitoring
Compliant with CDC, APHI, and the Laboratory Response Network
Analysis of powders
Norwalk Virus Testing
Anthrax Testing
[return to top]